FDA Brief

Company record

UCB Biosciences Inc.

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about UCB Biosciences Inc..

Recalls

ReportedClassFirmProduct and reason
May 27 Class II UCB Biosciences Inc.
Drug
cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, …
Lack of Assurance of Sterility